Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease.
Alzheimer’s disease
amyloid-PET
diffusion MRI
free water
white matter
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
medline:
18
5
2023
pubmed:
26
1
2023
entrez:
25
1
2023
Statut:
ppublish
Résumé
White matter (WM) injury is frequently observed along with dementia. Positron emission tomography with amyloid-ligands (Aβ-PET) recently gained interest for detecting WM injury. Yet, little is understood about the origin of the altered Aβ-PET signal in WM regions. Here, we investigated the relative contributions of diffusion MRI-based microstructural alterations, including free water and tissue-specific properties, to Aβ-PET in WM and to cognition. We included a unique cohort of 115 participants covering the spectrum of low-to-severe white matter hyperintensity (WMH) burden and cognitively normal to dementia. We applied a bi-tensor diffusion-MRI model that differentiates between (i) the extracellular WM compartment (represented via free water), and (ii) the fiber-specific compartment (via free water-adjusted fractional anisotropy [FA]). We observed that, in regions of WMH, a decrease in Aβ-PET related most closely to higher free water and higher WMH volume. In contrast, in normal-appearing WM, an increase in Aβ-PET related more closely to higher cortical Aβ (together with lower free water-adjusted FA). In relation to cognitive impairment, we observed a closer relationship with higher free water than with either free water-adjusted FA or WM PET. Our findings support free water and Aβ-PET as markers of WM abnormalities in patients with mixed dementia, and contribute to a better understanding of processes giving rise to the WM PET signal.
Identifiants
pubmed: 36695071
doi: 10.1177/0271678X231152001
pmc: PMC10196746
doi:
Substances chimiques
Water
059QF0KO0R
Banques de données
ClinicalTrials.gov
['NCT02330510']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
921-936Subventions
Organisme : NIA NIH HHS
ID : U01 AG024904
Pays : United States
Références
Neuroimage. 2014 May 15;92:27-35
pubmed: 24503415
Neuropathol Appl Neurobiol. 2007 Aug;33(4):410-9
pubmed: 17442062
Stroke. 2014 Jun;45(6):1721-6
pubmed: 24781079
Neuroimage. 2011 Apr 1;55(3):880-90
pubmed: 21182970
Micron. 2004;35(7):503-42
pubmed: 15219899
Neuroimage. 2011 Jan 15;54(2):963-73
pubmed: 20849961
J Nucl Med. 2018 Oct;59(10):1583-1589
pubmed: 29674420
Ann Clin Transl Neurol. 2019 Mar 03;6(4):678-688
pubmed: 31019992
J Neuropathol Exp Neurol. 2017 Apr 1;76(4):299-312
pubmed: 28431180
Ann Neurol. 2022 Dec;92(6):992-1000
pubmed: 36054513
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Neuroimage. 2015 Mar;108:450-9
pubmed: 25482269
Magn Reson Med. 2009 Sep;62(3):717-30
pubmed: 19623619
J Nucl Med. 2022 Aug;63(8):1239-1244
pubmed: 34916245
Hum Brain Mapp. 2022 May;43(7):2089-2108
pubmed: 35088930
Ann Neurol. 2011 Apr;69(4):673-80
pubmed: 21337603
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1242-1253
pubmed: 34581847
Front Neurosci. 2020 Dec 14;14:598868
pubmed: 33381009
Alzheimers Res Ther. 2022 Feb 12;14(1):33
pubmed: 35151361
Neurology. 2018 Jun 12;90(24):e2119-e2126
pubmed: 29769375
JAMA Neurol. 2014 Jan;71(1):23-31
pubmed: 24217171
Sci Rep. 2021 Mar 26;11(1):6990
pubmed: 33772083
Brain. 2008 Mar;131(Pt 3):665-80
pubmed: 18263627
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407
pubmed: 24647577
Acta Neuropathol. 1997 Apr;93(4):334-40
pubmed: 9113198
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
J Nucl Med. 2017 Aug;58(8):1285-1292
pubmed: 28062596
Brain Commun. 2022 Jun 06;4(3):fcac142
pubmed: 35694147
Neuroimage. 2012 Jan 16;59(2):1394-403
pubmed: 21924365
J Magn Reson Imaging. 2019 Feb;49(2):456-465
pubmed: 30635988
Neurology. 1995 Nov;45(11):2077-84
pubmed: 7501162
J Neurosci. 2012 Nov 28;32(48):17365-72
pubmed: 23197727
Neuroscience. 2014 Sep 12;276:14-28
pubmed: 24051366
Neuroradiology. 2018 Sep;60(9):933-944
pubmed: 30030550
J Nucl Med. 2009 Nov;50(11):1887-94
pubmed: 19837759
Sci Transl Med. 2012 Aug 15;4(147):147ra111
pubmed: 22896675
Front Neurol. 2020 Oct 16;11:541377
pubmed: 33178101
Am J Pathol. 2004 Aug;165(2):357-71
pubmed: 15277212
J Nucl Med. 2017 Sep;58(9):1483-1489
pubmed: 28336779
Neuroimage Clin. 2013 Jul 27;3:180-95
pubmed: 24179862
Brain. 2013 Sep;136(Pt 9):2697-706
pubmed: 23842566
Neuroinformatics. 2021 Oct;19(4):597-618
pubmed: 33527307
PLoS One. 2017 Dec 6;12(12):e0189155
pubmed: 29211812
J Nucl Med. 2019 Oct;60(10):1444-1451
pubmed: 30877180
J Alzheimers Dis. 2018;62(4):1595-1607
pubmed: 29504529
Mol Med. 2003 Mar-Apr;9(3-4):112-22
pubmed: 12865947
Alzheimers Res Ther. 2017 Aug 17;9(1):63
pubmed: 28818116
J Nucl Med. 2015 Apr;56(4):567-74
pubmed: 25745095
Eur J Neurol. 2013 Feb;20(2):243-50
pubmed: 22742818
Neuroimage Clin. 2015 Sep 29;9:479-83
pubmed: 26594630
Alzheimers Dement. 2018 Jun;14(6):764-774
pubmed: 29406155
Stroke. 2015 Jan;46(1):262-4
pubmed: 25395414
JAMA Neurol. 2017 Jan 01;74(1):41-49
pubmed: 27842175
Neurology. 2017 Mar 14;88(11):1077-1080
pubmed: 28202707
AJNR Am J Neuroradiol. 2006 Sep;27(8):1717-24
pubmed: 16971621
Neurobiol Aging. 2015 Feb;36(2):909-18
pubmed: 25457555
Alzheimers Dement. 2023 Apr;19(4):1503-1517
pubmed: 36047604
Neurology. 2019 May 7;92(19):e2221-e2231
pubmed: 30952798
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):515-26
pubmed: 26550542
Acta Neuropathol Commun. 2014 Aug 17;2:83
pubmed: 25129614
J Nucl Med. 2009 Feb;50(2):198-204
pubmed: 19164220